Short sellers are making aggressive moves. CAR (Avis Budget Group) now has 47.5% of its free float sold short, up from 40.4% last week. Bears are clearly betting on more pain for car rental. AI play CBRS (Cerebras Systems) sits at 31.6% SI % FF with zero shares left to borrow — a classic squeeze setup. GRND (Grindr) climbed from 16.7% to 22.5% short interest. On the options side, RUM (Rumble) is a parallel flashpoint. Utilization hit 100% and borrow availability collapsed to just 0.43% of short interest.
Insider signals are pulling in opposite directions. Summit Therapeutics CEO Bob Duggan filed a $50M buy at $13.12 per share. SMMT also saw its CFO and President buy in the same fortnight — three C-suite insiders buying in two weeks is a strong internal confidence signal. Meanwhile, Marc Andreessen filed $75.6M in sales of (Samsara) between June 8–11. The tech venture heavyweight is heading for the exit.
INTU was hit with a downgrade Wednesday. The $77 billion tax software firm faces growing AI disruption fears. FDX got the opposite treatment — analysts lifted the average target to $328, backed by 18 buy ratings. FedEx also reports Q4 results this week, making it a dual catalyst to watch.
KR kicks off today with Q1 results. CCL and FDX report Tuesday. MU (Micron) reports later in the week — a key read on AI-driven chip demand. In Europe, BAB (Babcock International) posts annual results Monday, watched closely amid rising UK defence spending.
Steel names NUE (Nucor) and STLD (Steel Dynamics) beat Q2 EPS guidance, sparking a rush into call options with little short interest friction in either name.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
